VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Haisco's Innovative Drug HSK46256 Tablet Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors
Haisco's Innovative Drug HSK46256 Tablet Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors
Jun 11, 2026 16:54 CST Updated 17:18
Share:
Haisco
New Drug Research and Development, Production, and Sales